TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A 16-year study of 15,576 older adults in Hong Kong found that moderate and severe visual impairment were associated with higher subsequent dementia risk. The observational findings do not show that vision loss causes dementia or that correcting eyesight prevents it.
A 16-year study of 15,576 adults aged 65 and older in Hong Kong found that moderate or severe vision impairment was associated with a higher risk of developing dementia than normal vision. The findings, published in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, suggest that eyesight may help identify older adults who could merit closer cognitive monitoring, but they do not show that vision loss causes dementia or that correcting eyesight prevents it.
Researchers followed community-dwelling participants who attended 18 government Elderly Health Centers. At the study’s start, their mean age was 74.5 years, 63.8% were women, and participants were clinically confirmed to be free of dementia. Over 168,434 person-years of follow-up, 3,643 people, or 23.4% of the cohort, developed dementia.
Vision was measured using a six-meter Snellen E chart, with participants wearing their usual optical correction. The researchers grouped acuity into normal, mild, moderate and severe impairment. After statistical adjustment and an analysis designed to reduce the possibility that early dementia explained the vision findings, moderate impairment was associated with a 42% higher dementia hazard than normal vision; severe impairment was associated with a 57% higher hazard. These are relative hazard estimates, not the percentage of participants who developed dementia.
The analysis excluded dementia cases from the first six years and assessed outcomes during years seven through 16. In that analysis, mild impairment was not statistically associated with dementia at the conventional threshold, with a reported p-value of 0.06. That result does not establish that mild vision loss carries no risk. The researchers also estimated that moderate and severe impairment were associated with 1.5 and 2.1 fewer dementia-free years, respectively, over 16 years, based on group-level survival curves.
Vision Measures May Aid Risk Monitoring
The study adds long-term evidence to a question that earlier research often examined using shorter or retrospective data, or by treating visual impairment as simply present or absent. By considering both severity and change in visual acuity, the researchers found that the association was stronger at poorer levels of vision, and that faster decline added to the association in parts of the analysis.
For clinicians and older adults, the results point to vision as a possible marker to note when considering who may need closer attention to cognitive health. They do not establish that vision testing can diagnose dementia, nor do they provide a validated screening rule for individual patients. The study also highlights a practical issue: some cognitive screening tools use visual tasks, so poor eyesight may affect test performance and complicate interpretation.
The findings should not be read as evidence that glasses, cataract surgery or other vision treatment reduces dementia risk. The researchers examined associations, not the effects of assigning participants to vision treatment. Keeping eyesight corrected may have other benefits, but prevention of dementia was not tested or demonstrated in this study.
As an affiliate, we earn on qualifying purchases.
How Researchers Tracked Vision and Dementia
The study followed Chinese adults aged 65 or older who attended health centers in Hong Kong. Their visual acuity was measured at baseline and follow-up, and higher LogMAR values represented poorer vision. The four categories were normal vision below 0.3 LogMAR, mild impairment from 0.3 to 0.47, moderate impairment from 0.48 to 0.99, and severe impairment at 1.00 or higher.
Dementia diagnoses were based on International Classification of Diseases, Tenth Revision, criteria or Clinical Dementia Rating scores, with diagnoses independently reviewed by geriatric psychiatrists. The study included nonvisual cognitive tests and clinical history. To address reverse causation—the possibility that early, unrecognized dementia contributed to vision changes—the principal analysis set aside cases arising during the first six years and participants whose dementia-free status at year six could not be confirmed.
That approach reduces one concern but cannot rule out all effects of preclinical disease or other differences between participants. The researchers also reported that cataract and glaucoma were not independently associated with dementia after adjustment for visual acuity. However, information about the severity, subtype, duration and treatment of those eye conditions was unavailable, limiting what can be concluded about them.
“Visual acuity could help assess subsequent dementia risk.”
— Study authors, as summarized in the News-Medical report
Cause, Treatment and Individual Risk
The study is observational, so it cannot establish whether worsening vision contributes to dementia, whether early neurodegenerative changes affect vision, or whether shared health and social factors influence both. The six-year exclusion was intended to reduce reverse causation, but it cannot remove every possibility that dementia-related changes were already present.
The reported hazard ratios describe differences between groups after adjustment; they do not predict an individual participant’s outcome. The study-specific modeled thresholds for acuity and rapid decline should not be treated as clinical cutoffs. It is also unclear from these results whether treating particular causes of vision loss would alter dementia risk. The report provides no trial evidence that glasses, surgery or other interventions prevent dementia.
Testing Findings in Other Populations
The findings need to be tested in other populations and study designs, including research that can better distinguish whether vision loss is a cause, an early sign, or a companion of processes that also raise dementia risk. Further work could assess whether results differ by underlying eye condition, its severity and treatment—details not available in this study.
For now, the research supports treating measured vision loss as a potential factor to consider alongside other health information, not as a dementia diagnosis or prevention strategy. The study report does not announce a clinical guideline or a planned follow-up milestone. Whether vision monitoring improves dementia detection, and whether treating impairment affects long-term cognitive outcomes, remains an open research question.
Key Questions
What did the 16-year study find?
Among 15,576 older adults in Hong Kong, moderate and severe vision impairment were associated with higher subsequent dementia hazard than normal vision in an analysis that excluded cases from the first six years. The study found an association, not proof that vision loss causes dementia.
How much higher was the reported dementia risk?
In the adjusted analysis, moderate impairment was associated with a 42% higher hazard and severe impairment with a 57% higher hazard compared with normal vision. These are relative hazard estimates, not absolute probabilities for an individual.
Does correcting vision prevent dementia?
The study did not test vision treatment as a way to prevent dementia. Its findings do not show that glasses, surgery or other correction lowers dementia risk.
Did mild vision impairment raise dementia risk?
After the analysis excluded dementia cases from the first six years, mild impairment was not statistically associated with dementia at the conventional threshold. A p-value of 0.06 does not establish that mild impairment carries no risk.
Why did researchers exclude early dementia cases?
Because dementia-related changes can develop before diagnosis, the researchers excluded cases arising in the first six years to reduce the possibility that preclinical dementia had contributed to vision decline. This step reduces, but does not eliminate, concern about reverse causation.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
